medigraphic.com
Revista Latinoamericana de Microbiología

2005, Number 1-2

<< Back Next >>

Microbiología 2005; 47 (1-2)

Neonatal candidiasis in Venezuela: Clinical and epidemiological aspects

Hartung CC, Mata-Essayag S, Azpiróz A, Ponente A, Magaldi S, Pérez C, Roselló A, Colella MT, Machuca J

Language: English
References: 69
Page: 11-20
PDF size: 93.86 Kb.


ABSTRACT

A prospective study of the clinical and epidemiological aspects of Candida spp. sepsis was performed to assess the frequency, etiology, and risk factors in the neonatology service of the Pediatrics Hospital “Dr. Elías Toro” (2002-2003). Forty four out of 128 neonatal intensive care patients, with clinical sepsis and suspected fungal etiology, were chosen randomly for this study. Infant blood, urine, gastrointestinal tract, oral and skin samples were cultured. Samples were also taken from health care worker hands and the environment. The antifungal susceptibility patterns of the isolates were evaluated. The prevalence of Candida spp. from the clinical samples was: C. albicans (72.06%), C. parapsilosis (13.24%), C. tropicalis (10.29 %), C. guilliermondii (2.94%), and C. glabrata (1.47%). Due to the similarity of the susceptibility pattern of some isolates from infants and health care workers, we speculate a horizontal nosocomial infection. Statistical analysis revealed the following significant risk factors associated with Candida spp. isolation: prolonged hospitalization (p ‹ 0.05), missing prenatal birth control (p ‹ 0.05), and parenteral nutrition (p ‹ 0.05). Blood cultures were all negative for bacteria and only 2.90% were positive for Candida spp. All 44 neonates receiving empirical therapy with amphotericin B (0.5-1.0 mg/k/day) evolved satisfactorily.


REFERENCES

  1. Ministerio de Sanidad y Desarrollo Social. Anuario de Epidemiología y Estadística Vital. 1998. Caracas, Venezuela.

  2. Bacci, S. 1994. Candidiasis invasiva en pacientes no neutropénicos. Ant E Inf. 2(4):21-37.

  3. Bakr, A.F. 2003. Intravenous lines-related sepsis in newborn babies admitted to NICU in a developing country. J Trop Pediatr. 49:295-7.

  4. Beck Sague, C.M., W.R. Jarwis & The National Nosocomial Infections Surveillance System. 1993. Secular trends in the epidemiology nosocomial fungal infections in the United States 1980-1990. J Infect Dis. 167:1247-51.

  5. Benjamin, D.K., K. Ross, R.K. McKinney, D. Benjamin, .Auten & R.G. Fisher. 2000. When to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase negative staphylococcal bacteremia. Pediatrics. 106(4):712-718.

  6. Benjamin, D.K., E.R. DeLong, W.J. Steinbach, C.M. Cotton, T.J. Walsh & R.H. Clark 2003. Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics. 112(1):543-7.

  7. Botas, C., I. Kurlat, S. Young & A. Sola. 1995. Candidiasis diseminada e hidrocortisona intravenosa en niños pretérmino. Pediatrics (ed. Esp). 39(6): 373-379.

  8. Butler, K., M. Rench & C. Baker. 1990. Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates. Pediatr Infect Dis J. 9:51-6.

  9. Campbell, J., E. Sacaría & C. Baker. 2000. Candidiasis sistémica en niños de muy bajo peso al nacer tratados por vía tópica con crema de petrolato para el cuidado de la piel: estudio de casos y controles. Pediatrics (ed. Esp.). 49(5): 293-297.

  10. Canton, E., A. Viudes & J. 2001. Pernán. Infección Sistémica Nosocomial por Levaduras. Rev Iberoam Micol. 18:51-55.

  11. Carrabs M, A. Garcia & A. Romero. 1991. Infecciones Intrahospitalarias Neonatales. MSc thesis in pediatrics, Facultad de Medicina Caracas, Universidad Central de Venezuela.

  12. Carrasco Sánchez, P., M.L.Castillo Montero, A. Bejarano Palmna, A. López Sanz, M. Santana Gallinato, C. Sáenz Reguera, L. Durán Vargas & A. González Meneses. 1999. Candidiasis neonatales y tratamiento con anfotericina B liposomal, nuestra experiencia. Anales Españoles de Pediatria. 51(3):273-280.

  13. Chacin, G. & H. Rangel. 1990. Infección sistémica por Candida albicans en el recien nacido- tratamiento con ketoconazol. Arch Venez Puericul y Pediat. .53:79-84.

  14. Chowdhary, A., K. Becker, W. Fegeler, H.C. Gugnani, L. Kapoor, V.S. Randhawa, G. Mehta. 2003. An outbreak of candidemia due to Candida tropicalis in a neonatal intensive care unit. Mycoses. 46(8):287-92.

  15. Coleman, D., M. Rinaldi, K. Haynes, R. Summerbell, E. Anaissie & L. Sullivan. 1998. Importance of Candida species other than Candida albicans as opportunistic pathogens. Med Mycol. 36(1):156-65.

  16. Da Silva, C.L., R.M. dos Santos & A.L. Colombo. 2001. Cluster of Candida parapsilosis primary bloodstream infection in a neonatal intensive care unit. Braz J Infect Dis. 5(1):32-6.

  17. Douglas, J.L. 2003. Candida biofilms and their role in infection. Rev Trends Microbiol. 11(1):30-36.

  18. Fairchild, K.D., S. Tomkoria, E. Sharp & F.V. Mena. 2002. Neonatal Candida glabrata sepsis: clinical and laboratory features compared with other Candida species. Pediatr Infect Dis J. 21:39-43.

  19. Feo, M. 1977. The nascent culture and its use. Mycopathologia. 63:185-186.

  20. Fotedar, R., E.T. Banerjee & A.R. Cahudhary. 2000. Outbreak of systemic candidiasis in low birth weight preterm infants at a neonatal intensive care unit. J Mycol Med. 10:100-104.

  21. Gary, A.B. & J. Toney. 1998. Infection versus colonization in the critical care unit. Pp. 71-90. In: Cunha, B. (Ed). Critical Care Clinics infections in Critical Care I volume 14, (1) Saunders Company, New York.

  22. Hall, R.T., S.L. Hall, W.G. Barnes, M.R. Izuegbu, I. Zorbas. 1987. Characteristics of coagulase-negative staphylococci from infants with bacteremia. Pediat Infect Dis J. 6:377-383.

  23. Huang, Y.C., T.Y. Lin, R.I. Lien, Y.H. Chou, C.Y. Kou, P.H. Yang & W.S. Hsieh. 2000. Candidaemia in special care nurseries: comparison of albicans and parapsilosis infection J Infect. 40(2):171-5.

  24. Hugonnet, S., H. Sax, P. Eggimann, J.C. Chevrolet & D. Pittet. 2004. Nosocomial bloodstream infection and clinical sepsis. Emerg Infect Dis [serial online] Jan [date cited]. Available from: URL:http://www.cdc.gov/ncidod/EID/voll10no1/03-0407.htm.

  25. Hunter, P., G. Harrison & C. Fraser. 1990. Cross-infection and diversity of Candida albicans strain carriage in patients and nursing staff on an intensive care unit. J Med Vet Mycol. 28:317-325.

  26. Itzhak, L., R. Olry, V. Sanjee, S. Vasishta, V. Tucci & S. Sood. 1998. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis. 26:1086-88.

  27. Jabra-Rizk, M.A., W.A. Falkler & TF. Meiller. 2004. Fungal Biofilms and Drug Resistance CDC 10 (1) [serial online] [date cited]. Available from: http//www.cdc.gov/ncidod/EID/vol10no 1/03-0119.hym.

  28. Jaraba Caballero, S., M. P. Jaraba Caballero, F. Fernández, I. Muriel, M.D. Huertas, R. Álvarez, J. Guzmán & M. Zapatero. 1998. Estudio prospectivo de sepsis por Candida en el RN. Anales Españoles de Pediatria. 48(6):639-44.

  29. Jarvis, W.R. 1995. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis; 20(6):1526-1530.

  30. Johansen, H.K. & P.C. Gøtzsche. 2003. Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients (Cochrane Review).pp. 233-257. In: The Cochrane Library, Issue 4, Chichester, UK: John Wiley & Sons, Ltd.

  31. Kossoff, E., S. Buescher & G. Karlowicz. 1998. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J. 17(5):504-508.

  32. Krcméry, V., M. Fric, M. Pisarcikova, M. Huttova, J. Filka, K. Kralinsky, H. Hupkova, J. Hanzen, J. Trupl & M. Liskova. 2000. Fungemia in neonates: report of 80 cases from seven University Hospitals. Pediatrics. 105(4):913-914.

  33. Krcmery, V., M. Huttova, F. Mateicka, L. Laho, L. Jurga, A. Ondrusova, Z. Tarekova, K .Kralinsky, J. Hanzen, A. Liskova, M. Mrazova, A. Sabo, M. Pisarcikova, G. Kovacicova, D. Chovancova & Z. Szovenyiova. 2001. Breakthrough fungemia in neonates and infants caudes by Candida albicans and Candida parapsilosis susceptible to fluconazole in vitro. J Antimicrob Chemother. 48(4):521-525.

  34. Larson, B.E. 1995. The 1992, 1993, and 1994 APIC Guideline Committees. APIC guideline for hand washing and hand antisepsis in health care settings. Am J Infect Control. 23:251-69.

  35. Laskus, A., W. Mendling, K. Runge & L. Schmidt. 1998. Candida septicemia in premature babies: a nosocomial infection? Mycoses. 41(2): 37-40.

  36. J.B. López Sastre, D. Coto Cotallo, B. Fernandez Colomer & Grupo de Hospitales Castrillo. 2002. Neonatal sepsis of nosocomial origin: an epidemiological study from the “Grupo de Hospitales Castrillo”. J Perinat Med. 30(2): 149-157.

  37. Macphail, G.L., G.D. Taylor, M. Buchanan-Chell, C. Ross, S. Wilson & A. Kureishi. 2002. Epidemiology, treatment and outcome of candidemia: a five-year review at three Canadian hospitals. Mycoses. 45(5-6):141-5.

  38. Magaldi, S., T. Camero, S. Mata, C. Marcano & C. Hartung. 1998. Pruebas de sensibilidad de Candida albicans frente a los antimicóticos de uso comercial. Bol Soc Venez Microbiol. 18:16-20.

  39. Magaldi, S., T. Camero. 1997. Susceptibilidad de Candida albicans “in vitro” mediante los pozos de difusión. Bol Venez de Infecto. l7:5-8.

  40. Magaldi, S., S. Mata, C. Hartung, G. Verde, L Deibis, Y. Roldan & C. Marcano. 2000. “In vitro” susceptibility of 137 Candida sp. isolates from HIV positive patients to several antifungal drugs. Mycopathologia. 149:63-68.

  41. Magaldi, S., C. Hartung, G. Verde, L. Spencer & S. Mata. 2001. In vitro susceptibility to fluconazole of Candida spp. isolates comparing three different methods. J Mycol Med. 11:123-126.

  42. Magaldi, S., S. Mata Essayag, C. Hartung de Capriles, C. Pérez, M.T. Colella, C. Olaizola & Y. Ontiveros. 2004. Well diffusion for antifungal susceptibility testing. I J I D. 8:39-45.

  43. Makhoul, I..R, P. Sujov, L. Ardekian, I. Kassis, T. Smolkin, J. I. Abu-elnaa’, A. Tamir & D. Laufer. 2002. Factors influencing oral colonization in premature infants. Isr Med Assoc J. 4(2):98-102.

  44. Mata-Essayag, S. 1993. Clamped homogeneous Electric Gel Electrophoresis Typing of Candida albicans isolates from HIV patients. PhD Thesis in Microbiology, University of Manchester, Manchester, England.

  45. Mata-Essayag, S. 2002. Anfotericina B: algunos aspectos relevantes. Actualización en Infectología. 18(3):2-10.

  46. Melville, C., S.T. Kempley, G.L. Darmstadt, J.G. Dinulos & Z. Miller. 2001. Treatment of Invasive Candida Infection in Neonates With Congenital Cutaneous Candidiasis. (Letter to the Editor). Pediatrics. 7:45.

  47. Mermel, L.A. & D.G. Maki. 1993. Detection of bacteremia in adults: consequences of culturing an inadequate volume of blood. Ann Intern Med. 119:270–272.

  48. Mongkolrattanothai, K., K. Chokephaibulkit, T. Kolatat, N. Vanprapar, S. Chearskul, N. Srihapol, V. Pumsawan, S. Pkaworawuth & C. Dhiraputra. 2001. Nosocomial bloodstream infection in pediatric patients: Siriraj Hospital, Bangkok; 1996-1999. J Med Assoc Thai. 84(2):160-5.

  49. Narang, A., P. Agrawal, A. Chakrabarti & P. Kumar. 1998. Epidemiology of systemic candidiasis in a tertiary care neonatal unit. J Trop Pediatrics. 44:104-108.

  50. Omaña Y, Rojas R. 1998. Infecciones por hongos en recién nacidos sépticos. Thesis Pediatrics, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela.

  51. Padovani, E.M., F. Michielutte, Dall’Agnole & Dal-Moro K. 1997. Sepsis caused by Candida in neonatal period. Pediatr Med Chir. 19:8-83.

  52. Pera, A., A. Byun, S. Gribar, R. Schwartz, D. Kumar & P. Pa. 2002. Dexamethasone therapy and Candida sepsis in neonates less than 1250 grams. J Perinatol. 22(3): 204-8.

  53. Pittet, D., M. Monod, P.M. Suter, E. Frenk & R. Auckenthaler. 1994. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 220:751-8.

  54. Ramírez, I., H. Mayerling, D. Daniel & M. Manrique. 1999. Candidiasis Neonatal. Estudio Clínico y Epidemiológico realizado en la Ciudad Hospitalaria “Dr. Enrique Tejera” Antib e Inf. 7(1): 21-30.

  55. Rangel, F., T. Wiblin, H. Blumberg, L. Saiman, J. Patterson, M. Rinaldi et al. 1999. National Epidemiology of Mycoses Survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal care units. Clin Infect Dis. 29:253-258.

  56. Rex, J.J., M.A. Pfaller, J.N. Galgiani, et al. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis. 24:235-247.

  57. Richards, M.J., J.R. Edwards, D.H. Culver & R.P. Gaynes. 1999. Nosocomial infections in medical intensive care units in the United States. Crit Care Med. 27:887–92.

  58. Rios Fabra, A. 1992. Fungemias en pacientes criticamente enfermos. Ant E Inf. 1(1): 30-37.

  59. Robinson, L.G., L. Jain & A.P. Kourtis. 1999. Persistent candidemia in a premature infant treated with fluconazole. Pediatr Infect Dis J. 18:735-737.

  60. Rowen, J., J. Tate. 1998. Management of neonatal candidiasis. Pediat Infect Dis J. 17:1007-11.

  61. Safdar, N., D.G. Maki. 2002. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, Enterococcus, Gram-negative Bacilli, Clostridium difficile, and Candida. Ann Intern Med. 136:834-844.

  62. Saiman, L., E. Ludington, M. Pfaller, et al. 2000. Risk factors for candidemia in NICU patients Pediatr Infect Dis J. 19:319-24.

  63. Saiman L, Ludington E, Dawson JD, Paterson JE, Rangel-Frausto S, Wiblin RT, Blumberg HM, Pfalller M, Rinaldi M, Edwards JE, Wenzel RP, Jarvis W & The National Epidemiology of Mycoses Study Group. Risk factors for Candida species colonization of neonatal intensive care unit patients. J Pediatr Infect Dis J 2001;20(12):1119-24.

  64. Sanchez A, Johnston DA, Myers C, Edwards JE Jr., Mitchell AP, Filler SG. Relationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitro. Infect Immun 2004;72:598-601.

  65. Schwarze R, Penk A, Pittrow L. Treatment of candidal infections with fluconazole in neonates and infants. Eur J Med Res 2000; 5:203-208.

  66. Shelonka RL, Moser SA. Time to positive culture results in neonatal Candida septicemia. J Pediatr 2003 142 (5): 564-5.

  67. Tirodker UH, Nataro JP, Smith S, Las Casas L, Fairchild KD. Detection of fungemia by polymerase chain reaction in critically ill neonates and children. J Perinatol 2003; 23(2): 117-22.

  68. Vazquez J, Boikov D, Boikov S, Dajani A. Use of electrophoretic karyotyping in the evaluation of Candida infections in a neonatal intensive-care unit. ICHE 1997; 18:32-37.

  69. Walsh TJ, Seibel NL, Arndt C, et al. Amphotericin B liquid complex in pediatric patients with invasive fungal infections. Pediatr Infect Dis J. 1999;18:702-708.




2020     |     www.medigraphic.com